Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fergus J Couch

Showing results (241-250 of 563) with videos related to

Pageof 57
Sort By:
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
Human Molecular Genetics|March 26, 2015
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility lociSimon G Coetzee, Howard C Shen, Dennis J Hazelett, et al.
Nature Communications|January 19, 2026
Site-saturation functional screens identify PALB2 missense variants associated with increased breast cancer riskRick A C M Boonen, Sabine C Knaup, Roberta Menafra, et al.
Journal of the National Cancer Institute|October 15, 2025
Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancerDaniela Ottaviani, Mihaela Ola, Alessandra Allotta, et al.
JAMA Oncology|July 25, 2024
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A ReviewHeather H Cheng, Jeffrey W Shevach, Elena Castro, et al.
Cancer Research Communications|November 28, 2023
Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African AncestryRaymond W Hughley, Marco Matejcic, Ziwei Song, et al.
NAR Cancer|June 23, 2022
Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy responseKevin J Thompson, Roberto A Leon-Ferre, Jason P Sinnwell, et al.
NPJ Breast Cancer|November 29, 2025
Plasma assay of methylated DNA markers detects recurrent metastatic breast cancerKarthik V Giridhar, Jason P Sinnwell, Seth W Slettedahl, et al.
Breast Cancer Research and Treatment|October 15, 2014
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersXinglei Chai, Tara M Friebel, Christian F Singer, et al.
American Journal of Human Genetics|March 27, 2026
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline PALB2 sequence variantsMarcy E Richardson, Megan F H Bishop, Megan A Holdren, et al.
Pageof 57

Showing results (241-250 of 563) with videos related to

Sort By:
Pageof 57
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
Human Molecular Genetics|March 26, 2015
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility lociSimon G Coetzee, Howard C Shen, Dennis J Hazelett, et al.
Nature Communications|January 19, 2026
Site-saturation functional screens identify PALB2 missense variants associated with increased breast cancer riskRick A C M Boonen, Sabine C Knaup, Roberta Menafra, et al.
Journal of the National Cancer Institute|October 15, 2025
Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancerDaniela Ottaviani, Mihaela Ola, Alessandra Allotta, et al.
JAMA Oncology|July 25, 2024
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A ReviewHeather H Cheng, Jeffrey W Shevach, Elena Castro, et al.
Cancer Research Communications|November 28, 2023
Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African AncestryRaymond W Hughley, Marco Matejcic, Ziwei Song, et al.
NAR Cancer|June 23, 2022
Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy responseKevin J Thompson, Roberto A Leon-Ferre, Jason P Sinnwell, et al.
NPJ Breast Cancer|November 29, 2025
Plasma assay of methylated DNA markers detects recurrent metastatic breast cancerKarthik V Giridhar, Jason P Sinnwell, Seth W Slettedahl, et al.
Breast Cancer Research and Treatment|October 15, 2014
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersXinglei Chai, Tara M Friebel, Christian F Singer, et al.
American Journal of Human Genetics|March 27, 2026
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline PALB2 sequence variantsMarcy E Richardson, Megan F H Bishop, Megan A Holdren, et al.
Pageof 57